首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 製藥 > 全球治療用肉毒桿菌市場：2009年
產業/市場分類
製藥 (4452)
肥胖症治療 (48)
非專利藥 (117)
疫苗 (167)
神經疾病 (175)
骨頭疾病治療 (40)
動物用醫藥 (18)
處方藥 (89)
規章 (107)
感染疾病 (315)
精神病 (80)
製藥企業 (500)
糖尿病 (157)
癌症 (837)
藥物開發 (1246)
DDS (173)
OTC 非處方藥 (147)
市場調查報告書

全球治療用肉毒桿菌市場：2009年

Global Markets for Therapeutic Botulinum Toxin 2009

出版商 Millennium Research Group
出版日期 2008年07月 商品編碼 76548
內容資訊 英文  
價格
US $ 4197 Web Access and PDF Download (Single user license)
US $ 6300 Web Access and PDF Download (Corporate use license)


全球治療用肉毒桿菌市場：2009年 是由出版商Millennium Research Group在2008年07月所出版的。 這份英文市場調查報告書價格從美金4197起跳。

目錄

Abstract

The global therapeutic botulinum toxin (BTX) market, including the US, Europe (France, Germany, Italy, Spain, and the UK), and Japan, exceeded $600 million in 2008

Through 2013, growth will be fueled by the approval of new treatment indications of BTX, which will significantly expand procedure volumes and bolster unit demand

Table of Contents

TABLE OF CONTENTS

LIST OF EXHIBITS

EXECUTIVE SUMMARY

METHODOLOGY

1.0 GLOBAL THERAPEUTIC BOTULINUM TOXIN MARKET

  • 1.1 Market Overview
  • 1.2 Market Analysis
    • 1.2.1 Product Background
    • 1.2.2 Procedure Overview
    • 1.2.2.1 US Procedures
    • Cervical Dystonia Procedures
    • Blepharospasm Procedures
    • Strabismus Procedures
    • Severe Primary Axillary Hyperhidrosis
    • 1.2.2.2 European Procedures
    • 1.2.2.3 Japanese Procedures
    • 1.2.2.4 Emerging Procedures
    • 1.2.3 Market Forecast
    • 1.2.3.1 US Therapeutic Botulinum Toxin Market
    • 1.2.3.2 European Therapeutic Botulinum Toxin Market
    • 1.2.3.3 Japanese Therapeutic Botulinum Toxin Market
    • 1.2.4 Market Drivers and Limiters
    • 1.2.4.1 Market Drivers
    • 1.2.4.2 Market Limiters
  • 1.3 Competitive Analysis
    • 1.3.1 Leading Competitors
    • 1.3.2 Emerging Competitors

2.0 US THERAPEUTIC BOTULINUM TOXIN MARKET

  • 2.1 Market Overview
  • 2.2 Market Analysis
    • 2.2.1 Market Forecast
    • 2.2.2 Market Drivers and Limiters
    • 2.2.2.1 Market Drivers
    • 2.2.2.2 Market Limiters
  • 2.3 Competitive Analysis
    • 2.3.1 Leading Competitors
    • 2.3.2 Emerging Competitors

3.0 EUROPEAN THERAPEUTIC BOTULINUM TOXIN MARKET

  • 3.1 Market Overview
  • 3.2 Market Analysis
    • 3.2.1 Market Forecast
    • 3.2.2 Market Drivers and Limiters
    • 3.2.2.1 Market Drivers
    • 3.2.2.2 Market Limiters
  • 3.3 Competitive Analysis
    • 3.3.1 Leading Competitors
    • 3.3.2 Emerging Competitors

4.0 JAPANESE THERAPEUTIC BOTULINUM TOXIN MARKET

  • 4.1 Market Overview
  • 4.2 Market Analysis
    • 4.2.1 Market Forecast
    • 4.2.2 Market Drivers and Limiters
    • 4.2.2.1 Market Drivers
    • 4.2.2.2 Market Limiters
  • 4.3 Competitive Analysis
    • 4.3.1 Leading Competitors
    • 4.3.2 Emerging Competitors

APPENDIX A: MRG ACRONYMS AND INITIALISMS

APPENDIX B: SUPPLEMENTAL EXHIBITS

List of Exhibits

  • EXECUTIVE SUMMARY
  • Exhibit 1: Therapeutic BTX Market, Global (US$), 2007 - 2013
  • Exhibit 2: Therapeutic BTX Market, by Indication, US, as a % of Total, 2008 and 2013
  • Exhibit 3: Therapeutic BTX Market Units, Europe, 2007 - 2013
  • Exhibit 4: Therapeutic BTX Market, Japan (US$), 2007 - 2013
  • Exhibit 5: Leading Competitors in the Therapeutic BTX Market, Global, 2008

METHODOLOGY

  • Exhibit 6: Currency Exchange Rates, 2008

CHAPTER 1: GLOBAL THERAPEUTIC BOTULINUM TOXIN MARKET

  • Exhibit 7: Therapeutic BTX Market, by Country, Global (US$), 2007 - 2013 (Graphical Format)
  • Exhibit 8: Therapeutic BTX Product Overview, Global, 2008
  • Exhibit 9: Therapeutic BTX Procedures, by Country, Global, 2007 - 2013
  • Exhibit 10: Therapeutic BTX Procedures, by Procedure Type, US, 2007 - 2013
  • Exhibit 11: Therapeutic BTX Procedures, by Country, Europe, 2007 - 2013
  • Exhibit 12: Therapeutic BTX Procedures, Japan, 2007 - 2013
  • Exhibit 13: Therapeutic BTX Market, by Country, Global (US$), 2007 - 2013 (Tabular Format)
  • Exhibit 14: Therapeutic BTX Market, by Country, Global (€ , £, and ¥), 2007 - 2013 Exhibit 15: Drivers and Limiters of the Therapeutic BTX Market, Global
  • Exhibit 16: Leading Competitors in the Therapeutic BTX Market, by Country, as % of Total, Global, 2008

CHAPTER 2: US THERAPEUTIC BOTULINUM TOXIN MARKET

  • Exhibit 17: Therapeutic BTX Market, US (US$), 2007 - 2013 (Graphical Format)
  • Exhibit 18: Therapeutic BTX Market, US (US$), 2007 - 2013 (Tabular Format)
  • Exhibit 19: Therapeutic BTX Market Growth, US, 2008 - 2013
  • Exhibit 20: Drivers and Limiters of the Therapeutic BTX Market, US
  • Exhibit 21: Leading Competitors in the Therapeutic BTX Market, as a % of Total, US, 2008

CHAPTER 3: EUROPEAN THERAPEUTIC BOTULINUM TOXIN MARKET

  • Exhibit 22: Therapeutic BTX Market, by Country, Europe (US$), 2007 - 2013 (Graphical Format)
  • Exhibit 23: Therapeutic BTX Market, by Country, Europe (US$), 2007 - 2013 (Tabular Format)
  • Exhibit 24: Therapeutic BTX Market, by Country, Europe (€ and £), 2007 - 2013
  • Exhibit 25: Therapeutic BTX Market Growth, by Country, Europe, 2008 - 2013
  • Exhibit 26: Drivers and Limiters of the Therapeutic BTX Market, Europe
  • Exhibit 27: Leading Competitors in the Therapeutic BTX Market, by Country, as a % of Total, Europe, 2008

CHAPTER 4: JAPANESE THERAPEUTIC BOTULINUM TOXIN MARKET

  • Exhibit 28: Therapeutic BTX Market, Japan (US$), 2007 - 2013
  • Exhibit 29: Therapeutic BTX Market, Japan (US$ and ¥), 2007 - 2013
  • Exhibit 30: Therapeutic BTX Market Growth, Japan, 2008 - 2013
  • Exhibit 31: Drivers and Limiters of the Therapeutic BTX Market, Japan
  • Exhibit 32: Leading Competitors in the Therapeutic BTX Market, as a % of Total, Japan, 2008

APPENDIX B: SUPPLEMENTAL EXHIBITS

  • Exhibit 33: Therapeutic BTX Market, Global (US$), 2007 - 2013 (Detailed Format)
  • Exhibit 34: Therapeutic BTX Market, by Indication, US, as a % of Total, 2008 and 2013 (Detailed Format)
  • Exhibit 35: Therapeutic BTX Market Units, Europe, 2007 - 2013 (Detailed Format)
  • Exhibit 36: Therapeutic BTX Market, Japan (US$), 2007 - 2013 (Detailed Format)
Back to Top